Media Summary: Virginia Kaklamani, MD, UT Health San Antonio, San Antonio, TX, discusses the various Hope S. Rugo, MD, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses challenges in the ... This study is looking to decrease the amount of chemotherapy used for people with
Optimizing Treatment Options For Her2 - Detailed Analysis & Overview
Virginia Kaklamani, MD, UT Health San Antonio, San Antonio, TX, discusses the various Hope S. Rugo, MD, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses challenges in the ... This study is looking to decrease the amount of chemotherapy used for people with Presented By: Hillary Stires, PhD - Postdoctoral Fellow, Georgetown University Lombardi Comprehensive Cancer Center Speaker ... The session took place at 4 p.m. on Tuesday, Dec. 10, 2024. It was an Educational Session. YOUTUBE CHAPTERS 0:00 ... In this video BREAST CANCER CONNECT expert, Dr Sara Tolaney, discusses
In this interview, Dr. Kelly McCann, UCLA Health, outlines key considerations for sequencing therapies in hormone ... Sign up for my newsletter Order your copy of The Cancer Roadmap ... Dr Reshma Mahtani, DO from Miami Cancer Institute comments on the expanding HER2+ early breast cancer has been revolutionized by the development of Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, Korea, discusses
